Form 4 for NVAX NOVAVAX INC
Accepted 2025-01-02 00:00:00 ET · period of report 2024-12-13 · accession 0001593968-25-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-02 | 2024-12-13 | NVAX | King Rachel K. | Dir | S - Sale | $9.02 | -4,150 | 14.8K | -22% | -$37.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-13 | S | D | 4,150 | $9.02 | 14,770 | D | — | — |